Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live attenuated herpes zoster vaccine dose-ranging Phase II trial
CTR20160350Phase 2Completed
- Sponsor
- Changchun BCHT Biotechnology Co.
- Start
- Jun 2016
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by Changchun BCHT Biotechnology Co.. Started Jun 2016; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20160350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160350.